We are live on ! Find out more
SCP

Silverleafe Capital Partners Portfolio holdings

AUM $367M
1-Year Est. Return 37.49%
This Fund
S&P 500
This Quarter Est. Return
+4.85%
1 Year Est. Return
+37.49%
3 Year Est. Return
+82.76%
5 Year Est. Return
+101.4%
10 Year Est. Return
AUM
$166M
AUM Growth
-$2.36M
Cap. Flow
-$8.32M
Cap. Flow %
-5%
Top 10 Hldgs %
63.47%
Holding
85
New
10
Increased
23
Reduced
16
Closed
20

Sector Composition

Rank Sector Weight
1 Financials 12.92%
2 Industrials 11.64%
3 Communication Services 8.21%
4 Technology 5.33%
5 Healthcare 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
76
Johnson & Johnson
JNJ
$640B
-2,314
Closed -$323K
LLY icon
77
Eli Lilly
LLY
$1.08T
-2,192
Closed -$284K
LPLA icon
78
LPL Financial
LPLA
$27B
-3,853
Closed -$268K
MU icon
79
CALL
Micron Technology
MU
$835B
-400
Closed -$17K
NUE icon
80
Nucor
NUE
$58.3B
-26,996
Closed -$1.57M
QLD icon
81
ProShares Ultra QQQ
QLD
$11.7B
-87,208
Closed -$980K
SSO icon
82
ProShares Ultra S&P500
SSO
$7.52B
-64,328
Closed -$947K
T icon
83
AT&T
T
$164B
-9,463
Closed -$224K
UWM icon
84
ProShares Ultra Russell2000
UWM
$241M
-29,700
Closed -$1M
XLE icon
85
State Street Energy Select Sector SPDR ETF
XLE
$39B
-13,096
Closed -$433K

Similar funds

Silverleafe Capital Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Silverleafe Capital Partners held 85 positions worth $166M, down 1.4% from $169M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Silverleafe Capital Partners withdrew a net $8.32M in Q2 2019, closing 20 positions and reducing 16 holdings. Its most notable exit was Gilead Sciences, an estimated $2.24M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, Silverleafe Capital Partners opened a new position in Elevance Health worth $2.51M.

  • Silverleafe Capital Partners's largest Q2 2019 buy was Elevance Health: 8,891 shares worth $2.51M.
  • Silverleafe Capital Partners added most to Fidelity MSCI Financials Index ETF in Q2 2019, an estimated $2.03M increase.
  • Silverleafe Capital Partners's biggest Q2 2019 reduction was Cummins, cutting an estimated $2.69M.
  • Silverleafe Capital Partners fully exited Gilead Sciences in Q2 2019, selling an estimated $2.24M.
  • Silverleafe Capital Partners's ten largest holdings make up 63% of its $166M portfolio in Q2 2019.
  • Silverleafe Capital Partners opened 10 new positions and closed 20 in Q2 2019.
  • Silverleafe Capital Partners's portfolio value fell 1.4% quarter-over-quarter to $166M.

Based on Silverleafe Capital Partners's 13F filing for Q2 2019, filed 3 Jul 2019.